Complete Blood Count (CBC)
Written by: Sid Ahmed Abdala Balal, RN
Medically Reviewed by: Adam Sayedi, MD
Last Updated: January 26, 2026
What is a Complete Blood Count (CBC)?
The complete blood count (CBC) is one of the most commonly ordered blood tests, providing a comprehensive evaluation of the cellular components of blood. It measures the number, size, and maturity of different blood cells including red blood cells (erythrocytes), white blood cells (leukocytes), and platelets (thrombocytes). The CBC provides essential information for diagnosing infections, anemia, blood disorders, immune system problems, and monitoring treatment effectiveness.
Automated hematology analyzer; measures cell counts, sizes, and hemoglobin content from whole blood sample
Venous blood in EDTA (lavender/purple top) tube; typically 3-5 mL; pediatric samples 1-2 mL
Results typically available within 1-2 hours; STAT results in 30-60 minutes in emergency situations
No fasting required; test can be performed at any time; some medications may affect results
- Diagnose conditions: Anemia, infection, leukemia, immune disorders, clotting problems
- Monitor disease progression: Track response to treatment for cancer, chronic conditions
- Assess overall health: Routine screening, pre-operative evaluation, annual physical exams
- Evaluate symptoms: Fatigue, weakness, fever, bruising, bleeding, weight loss
When ordering a CBC, consider whether differential count is needed. A “CBC with diff” breaks down the five types of white blood cells (neutrophils, lymphocytes, monocytes, eosinophils, basophils), providing crucial information for diagnosing infection type (bacterial vs. viral), allergic reactions, parasitic infections, and blood cancers. For fever, suspected infection, or abnormal total WBC, always order the differential count.
CBC Components: What is Measured
Red Blood Cell (RBC) Parameters
- RBC Count: Total number of red blood cells per volume of blood; assesses oxygen-carrying capacity
- Hemoglobin (Hb or Hgb): Protein in RBCs that carries oxygen; directly measures oxygen-carrying capacity of blood
- Hematocrit (Hct or HCT): Percentage of blood volume occupied by red blood cells; correlates closely with hemoglobin
- Mean Corpuscular Volume (MCV): Average size of red blood cells; helps classify anemia (microcytic, normocytic, macrocytic)
- Mean Corpuscular Hemoglobin (MCH): Average amount of hemoglobin per red blood cell
- Mean Corpuscular Hemoglobin Concentration (MCHC): Average concentration of hemoglobin in red blood cells
- Red Cell Distribution Width (RDW): Variation in red blood cell size; elevated suggests mixed population of cell sizes
White Blood Cell (WBC) Parameters
- WBC Count: Total number of white blood cells; elevated in infection, inflammation, leukemia; decreased in bone marrow suppression
- Differential Count: Percentage and absolute count of each WBC type:
- Neutrophils: First responders to bacterial infection and tissue injury (40-70% of WBCs)
- Lymphocytes: T-cells and B-cells; fight viral infections and produce antibodies (20-40% of WBCs)
- Monocytes: Clean up debris and dead cells; elevated in chronic infection (2-8% of WBCs)
- Eosinophils: Combat parasites and mediate allergic reactions (1-4% of WBCs)
- Basophils: Release histamine in allergic reactions (0.5-1% of WBCs)
Platelet Parameters
- Platelet Count: Number of platelets (thrombocytes); essential for blood clotting
- Mean Platelet Volume (MPV): Average size of platelets; larger platelets are typically younger
- Platelet Distribution Width (PDW): Variation in platelet size
The differential can be reported as percentages (relative) or absolute numbers:
- Relative (%): What percentage each cell type represents of total WBCs; can be misleading if total WBC is abnormal
- Absolute count: Actual number of each cell type per volume; more clinically useful for diagnosis
- Example: A patient with WBC 2.0 (low) might have 70% neutrophils (seemingly normal %), but absolute neutrophil count is only 1.4 (neutropenia)
Normal CBC Values (Adult Reference Ranges)
Note: Normal ranges vary by age, sex, altitude, and laboratory. Always compare results to your specific laboratory’s reference ranges. Values below are typical adult references.
| Component | Adult Male Range | Adult Female Range | Units |
|---|---|---|---|
| RBC Count | 4.5-5.9 | 4.1-5.1 | × 10¹²/L (million/μL) |
| Hemoglobin | 13.5-17.5 | 12.0-15.5 | g/dL |
| Hematocrit | 39-49 | 35-45 | % |
| MCV | 80-100 | 80-100 | fL (femtoliters) |
| MCH | 27-33 | 27-33 | pg (picograms) |
| MCHC | 32-36 | 32-36 | g/dL |
| RDW | 11.5-14.5 | 11.5-14.5 | % |
| WBC Count | 4.5-11.0 | 4.5-11.0 | × 10⁹/L (thousand/μL) |
| Neutrophils | 40-70% (1.8-7.7 abs) | 40-70% (1.8-7.7 abs) | % (× 10⁹/L absolute) |
| Lymphocytes | 20-40% (1.0-4.8 abs) | 20-40% (1.0-4.8 abs) | % (× 10⁹/L absolute) |
| Monocytes | 2-8% (0.2-0.8 abs) | 2-8% (0.2-0.8 abs) | % (× 10⁹/L absolute) |
| Eosinophils | 1-4% (0.0-0.4 abs) | 1-4% (0.0-0.4 abs) | % (× 10⁹/L absolute) |
| Basophils | 0.5-1% (0.0-0.1 abs) | 0.5-1% (0.0-0.1 abs) | % (× 10⁹/L absolute) |
| Platelet Count | 150-400 | 150-400 | × 10⁹/L (thousand/μL) |
| MPV | 7.5-11.5 | 7.5-11.5 | fL (femtoliters) |
- Hemoglobin <7 g/dL or >20 g/dL: Severe anemia or polycythemia; may require urgent transfusion or intervention
- WBC <1.0 × 10⁹/L: Severe leukopenia; high infection risk requiring protective isolation
- WBC >30 × 10⁹/L: Possible leukemia, severe infection, or leukemoid reaction requiring urgent evaluation
- Platelet count <20 × 10⁹/L: Severe thrombocytopenia; spontaneous bleeding risk; may require platelet transfusion
- Platelet count >1000 × 10⁹/L: Extreme thrombocytosis; risk of thrombosis or bleeding
- Absolute neutrophil count (ANC) <0.5 × 10⁹/L: Severe neutropenia; neutropenic precautions required
Specimen Collection and Handling
Collection Procedure
- Tube type: EDTA (lavender or purple top) anticoagulated tube; prevents clotting and preserves cell morphology
- Volume: Adults 3-5 mL; pediatric 1-2 mL; neonates minimum 0.5 mL
- Collection site: Venipuncture from peripheral vein (typically antecubital fossa); avoid areas with IV infusion
- Patient preparation: No fasting required; patient can eat and drink normally
- Timing: Can be collected at any time; some facilities prefer morning collection for consistency
Critical Collection Steps
- Mixing: Immediately after collection, gently invert tube 8-10 times to mix blood with EDTA; inadequate mixing causes clotting
- Avoid hemolysis: Use appropriate needle gauge (21-22G for adults); avoid excessive vacuum or force; don’t shake vigorously
- Fill level: Fill to designated line on tube; underfilling causes dilution errors; overfilling causes inadequate anticoagulation
- Labeling: Label tube immediately at bedside with patient name, date of birth, date/time of collection, collector initials
- Transport: Send to laboratory within 4 hours; store at room temperature (not refrigerated or on ice)
Common Pre-analytical Errors to Avoid
- Wrong tube type: Using serum tube instead of EDTA causes clotting and specimen rejection
- Clotted specimen: Inadequate mixing or delayed mixing results in microclots; specimen must be recollected
- Hemolyzed sample: Excessive force, small needle, or vigorous mixing causes RBC lysis and falsely low RBC/Hgb/Hct
- Dilution errors: Drawing from IV line or above IV site dilutes sample; always draw from opposite arm or below IV
- Delayed processing: Holding sample >24 hours causes cell degradation and inaccurate results
- EDTA-dependent pseudothrombocytopenia: Rare phenomenon where platelets clump in EDTA; causes falsely low platelet count
When collecting multiple tubes, follow proper order of draw to prevent cross-contamination of additives. For CBC, the EDTA tube should be drawn after any coagulation tubes (blue top) but can be drawn before or after chemistry tubes. The standard order is: blood culture bottles, coagulation (blue), serum (red/gold), heparin (green), EDTA (purple), glycolysis inhibitor (gray). This prevents EDTA contamination of other tubes which would cause erroneous results.
Clinical Interpretation of Abnormal Results
Low Hemoglobin/Hematocrit (Anemia)
Classification by MCV:
- Microcytic (MCV <80 fL): Iron deficiency anemia (most common), thalassemia, chronic disease, lead poisoning
- Normocytic (MCV 80-100 fL): Acute blood loss, hemolysis, chronic kidney disease, chronic disease, bone marrow failure
- Macrocytic (MCV >100 fL): Vitamin B12 deficiency, folate deficiency, alcohol abuse, liver disease, hypothyroidism, medications (methotrexate, antiretrovirals)
Common symptoms: Fatigue, weakness, pallor, dyspnea on exertion, tachycardia, dizziness, cold intolerance
Nursing actions: Assess for bleeding source, dietary history, medication review; monitor vital signs and oxygen saturation; prepare for further testing (iron studies, B12/folate, reticulocyte count, peripheral smear); transfusion may be indicated if Hgb <7 g/dL or symptomatic
Elevated Hemoglobin/Hematocrit (Polycythemia)
Common causes:
- Relative polycythemia: Dehydration, diuretic use, burns (most common cause)
- Secondary polycythemia: Chronic hypoxia (COPD, high altitude, sleep apnea, smoking), renal tumors, erythropoietin-producing tumors
- Primary polycythemia (polycythemia vera): Myeloproliferative disorder; often accompanied by elevated WBC and platelets
Nursing actions: Assess hydration status and fluid balance; monitor for thrombosis risk (headache, visual changes, chest pain); review oxygen saturation and respiratory status; may require phlebotomy for symptomatic relief
Elevated WBC (Leukocytosis)
Differential diagnosis by cell type elevated:
- Neutrophilia: Bacterial infection (most common), inflammation, tissue necrosis, stress response, corticosteroids, smoking, post-splenectomy
- Lymphocytosis: Viral infection (EBV, CMV, viral hepatitis), chronic lymphocytic leukemia (CLL), pertussis
- Monocytosis: Chronic infection (TB, endocarditis), recovery from acute infection, inflammatory bowel disease, sarcoidosis
- Eosinophilia: Parasitic infection, allergic conditions, asthma, drug reactions, Hodgkin’s lymphoma, eosinophilic disorders
- Basophilia: Rare; seen in chronic myeloid leukemia (CML), myeloproliferative disorders, inflammatory conditions
Nursing actions: Assess for infection signs (fever, localized symptoms); review medication list; monitor temperature and vital signs; prepare for blood cultures if febrile; if WBC >30 or immature cells present (blasts, bands), urgent hematology consultation required for possible leukemia
Low WBC (Leukopenia/Neutropenia)
Common causes:
- Chemotherapy or radiation therapy (most common in oncology patients)
- Bone marrow disorders (aplastic anemia, myelodysplastic syndrome, leukemia)
- Medications (clozapine, carbimazole, immunosuppressants)
- Severe infections (overwhelming sepsis, typhoid, HIV)
- Autoimmune disorders (lupus, rheumatoid arthritis)
- Nutritional deficiencies (severe malnutrition, vitamin B12/folate deficiency)
Nursing actions: Institute neutropenic precautions if ANC <1.0 (private room, strict hand hygiene, no fresh flowers/plants, limit visitors); monitor closely for infection signs; educate patient on infection prevention; avoid rectal temperatures, injections, invasive procedures when possible; report fever immediately (neutropenic fever is medical emergency)
Low Platelets (Thrombocytopenia)
Common causes:
- Decreased production: Bone marrow suppression (chemotherapy, aplastic anemia, leukemia), nutritional deficiencies (B12, folate)
- Increased destruction: Immune thrombocytopenic purpura (ITP), drug-induced (heparin, antibiotics, anticonvulsants), disseminated intravascular coagulation (DIC)
- Sequestration: Splenomegaly (liver disease, portal hypertension)
- Dilutional: Massive transfusion, IV fluid resuscitation
- Pregnancy: Gestational thrombocytopenia, HELLP syndrome, pre-eclampsia
Bleeding risk by platelet level:
- >50 × 10⁹/L: Minimal bleeding risk; normal hemostasis for most procedures
- 20-50 × 10⁹/L: Increased bleeding with trauma or surgery; spontaneous bleeding uncommon
- 10-20 × 10⁹/L: Spontaneous bleeding may occur with minor trauma; platelet transfusion often indicated before invasive procedures
- <10 × 10⁹/L: High risk of spontaneous bleeding including intracranial hemorrhage; urgent platelet transfusion typically required
Nursing actions: Bleeding precautions (soft toothbrush, electric razor, avoid IM injections, avoid NSAIDs/aspirin); monitor for bleeding signs (petechiae, purpura, hematuria, melena, hemoptysis, gingival bleeding); measure blood pressure carefully (avoid excessive cuff pressure); avoid invasive procedures; educate on injury prevention; if <20 × 10⁹/L, consider platelet transfusion
Elevated Platelets (Thrombocytosis)
Common causes:
- Reactive (secondary): Infection, inflammation, iron deficiency, malignancy, post-splenectomy, bleeding, tissue damage (most common)
- Primary (essential thrombocythemia): Myeloproliferative disorder; platelets often >600 × 10⁹/L
Nursing actions: Assess for underlying inflammatory/infectious process; monitor for thrombotic events (DVT, PE, stroke, MI); paradoxically, very high platelet counts (>1000) may cause bleeding due to platelet dysfunction; may require antiplatelet therapy or cytoreduction
- Pancytopenia (low RBC, WBC, and platelets): Suggests bone marrow failure; requires urgent hematology consultation
- Blast cells on differential: Immature WBCs suggest acute leukemia; immediate hematology referral required
- Hemoglobin <7 g/dL with symptoms: Severe anemia; may require urgent transfusion
- WBC >30 × 10⁹/L: Possible leukemia or severe infection; requires urgent evaluation
- Platelets <20 × 10⁹/L: High bleeding risk; consider platelet transfusion and urgent hematology input
- Neutropenic fever: ANC <0.5 with temperature >38.3°C (100.9°F); medical emergency requiring immediate broad-spectrum antibiotics
Nursing Care Plans: CBC Abnormalities
Assessment
- Review CBC results: Hgb, Hct, MCV, RDW to classify anemia type (microcytic, normocytic, macrocytic)
- Assess symptoms: fatigue level, exercise tolerance, dyspnea, chest pain, dizziness, headache
- Physical examination: skin/conjunctival pallor, tachycardia, tachypnea, orthostatic vital signs
- Bleeding assessment: GI bleeding (melena, hematochezia), menorrhagia, hematuria, epistaxis
- Nutritional history: iron intake, vegetarian/vegan diet, B12/folate sources
- Medication review: NSAIDs, anticoagulants, aspirin, PPIs (reduce iron absorption)
Example Nursing Diagnoses
- Activity intolerance related to decreased oxygen-carrying capacity
- Risk for decreased cardiac output related to compensatory tachycardia
- Imbalanced nutrition: less than body requirements related to iron, B12, or folate deficiency
- Risk for injury related to dizziness and weakness
Planning and Goals
- Hemoglobin increases to target range appropriate for patient condition
- Patient reports improved energy and exercise tolerance
- Patient identifies and corrects nutritional deficiencies or bleeding sources
- No injury occurs related to anemia symptoms
Key Interventions and Rationales
- Monitor vital signs and oxygen saturation; assess for compensatory tachycardia and tachypnea; supplemental oxygen may be needed if symptomatic
- Assess activity tolerance; encourage rest periods between activities; assist with ADLs as needed to conserve energy
- Implement fall prevention: assist with ambulation, ensure call bell within reach, bed in low position; anemia causes dizziness and weakness
- Prepare for transfusion if ordered: typically indicated for Hgb <7 g/dL or symptomatic anemia; verify blood product, patient consent, IV access
- Administer iron supplementation as ordered: give on empty stomach with vitamin C for better absorption; warn about dark stools; separate from calcium/antacids
- Educate on iron-rich foods: red meat, dark leafy greens, fortified cereals, beans, dried fruits; vitamin C enhances absorption
- For B12/folate deficiency: administer supplements as ordered; B12 may require IM injections if pernicious anemia; educate on dietary sources
- Monitor for further bleeding: test stools for occult blood; monitor urine for hematuria; assess for GI symptoms requiring gastroenterology referral
- Arrange follow-up CBC: recheck in 2-4 weeks after starting iron therapy; 8-12 weeks for B12/folate therapy
Assessment
- Calculate absolute neutrophil count (ANC): (% neutrophils + % bands) × WBC ÷ 100
- Classify severity: Mild (1.0-1.5), Moderate (0.5-1.0), Severe (<0.5 × 10⁹/L)
- Infection screening: temperature every 4 hours; assess all body systems for infection signs
- Review causative factors: chemotherapy cycle, radiation therapy, medications
- Assess patient understanding of infection risk and prevention measures
Example Nursing Diagnoses
- Risk for infection related to immunosuppression from neutropenia
- Risk for sepsis related to severely compromised immune defenses
- Deficient knowledge related to neutropenic precautions and infection prevention
- Social isolation related to protective isolation requirements
Planning and Goals
- Patient remains free from infection during neutropenic period
- ANC returns to safe range (>1.0 × 10⁹/L) with treatment
- Patient demonstrates understanding of and compliance with neutropenic precautions
- Early detection and treatment of any infection that develops
Key Interventions and Rationales
- Implement neutropenic precautions: private room if ANC <1.0; strict hand hygiene for all entering room; limit visitors (no sick visitors); no fresh flowers, plants, or raw foods
- Monitor temperature every 4 hours and PRN; report fever >38.3°C (100.9°F) or >38°C (100.4°F) sustained for 1 hour immediately
- Neutropenic fever is medical emergency: requires blood cultures from peripheral and central lines, broad-spectrum antibiotics within 1 hour, sepsis protocol activation
- Meticulous infection surveillance: assess mouth, skin folds, perianal area, IV sites, catheter sites; mucositis and perirectal infections common in neutropenia
- Avoid invasive procedures when possible: no rectal temperatures, suppositories, or enemas; minimize injections; use smallest needle gauge necessary
- Oral care protocol: soft toothbrush or foam swabs; alcohol-free mouthwash; assess for mucositis; prophylactic antifungals may be ordered
- G-CSF (filgrastim) administration: give as ordered to stimulate neutrophil production; monitor for bone pain (common side effect)
- Patient education: explain infection risk, importance of reporting symptoms immediately (fever, chills, sore throat, dysuria, diarrhea), hand hygiene, food safety (no raw/undercooked foods), avoiding crowds
- Psychosocial support: isolation is distressing; ensure adequate communication with family; provide activities and emotional support
Assessment
- Review platelet count and trend; assess severity and bleeding risk
- Bleeding assessment: petechiae (especially lower extremities), purpura, ecchymoses, gingival bleeding, epistaxis, hematuria, melena
- Vital signs: assess for tachycardia or hypotension suggesting significant bleeding
- Neurological assessment: headache, vision changes, altered mental status (signs of intracranial hemorrhage)
- Review medications: heparin, antiplatelet agents, antibiotics, anticonvulsants that may cause thrombocytopenia
Example Nursing Diagnoses
- Risk for bleeding related to decreased platelet count
- Risk for ineffective cerebral tissue perfusion related to potential intracranial hemorrhage
- Deficient knowledge related to bleeding precautions
- Anxiety related to bleeding risk and lifestyle restrictions
Planning and Goals
- Patient experiences no bleeding episodes during thrombocytopenic period
- Early detection and management of any bleeding that occurs
- Patient demonstrates understanding of and compliance with bleeding precautions
- Platelet count increases to safe range with treatment
Key Interventions and Rationales
- Implement bleeding precautions: soft toothbrush or foam swabs for oral care; electric razor only; avoid IM injections, rectal procedures, invasive interventions when possible
- Blood pressure monitoring: use appropriate cuff size; avoid excessive pressure or repeated inflation on same arm; rotate sites
- Monitor for bleeding signs: skin assessment for petechiae/purpura/ecchymoses; test all excreta for occult blood (stool, urine, emesis); assess gums, nose, conjunctiva
- Neurological assessment: monitor for headache, confusion, vision changes, focal deficits; intracranial hemorrhage is most serious complication
- Medication safety: avoid antiplatelet agents (aspirin, NSAIDs, clopidogrel); review all medications for antiplatelet effects; coordinate with pharmacy
- Prepare for platelet transfusion: typically ordered for platelets <10-20 × 10⁹/L or <50 × 10⁹/L before procedures; verify blood product and patient; monitor for transfusion reactions
- Injury prevention: fall precautions; pad bed rails if severely thrombocytopenic or confused; avoid contact sports and high-risk activities
- Patient education: use soft toothbrush; electric razor; avoid flossing if platelets very low; no contact sports; avoid cuts and injuries; report bleeding immediately; avoid alcohol (increases bleeding risk)
- Dietary considerations: avoid foods that can cause GI trauma (sharp chips, hard candies); maintain adequate nutrition to support platelet production
❓ Frequently Asked Questions (FAQ)
1. What is a complete blood count (CBC)?
A CBC is a blood test that measures the number and characteristics of blood cells including red blood cells (which carry oxygen), white blood cells (which fight infection), and platelets (which help blood clot). It includes measurements like hemoglobin, hematocrit, WBC count, platelet count, and often a differential count of WBC types. It’s one of the most common laboratory tests ordered.
2. What are normal CBC values?
Normal ranges vary by age, sex, and laboratory, but typical adult values include: WBC 4.5-11.0 × 10⁹/L, RBC 4.5-5.9 × 10¹²/L (men) or 4.1-5.1 × 10¹²/L (women), hemoglobin 13.5-17.5 g/dL (men) or 12.0-15.5 g/dL (women), hematocrit 39-49% (men) or 35-45% (women), and platelets 150-400 × 10⁹/L. Always compare results to your specific laboratory’s reference ranges as they may vary.
3. What does low hemoglobin mean?
Low hemoglobin (anemia) means reduced oxygen-carrying capacity of blood. Common causes include iron deficiency, vitamin B12 or folate deficiency, chronic disease, bleeding (acute or chronic), hemolysis, or bone marrow disorders. Symptoms may include fatigue, weakness, pallor, shortness of breath, dizziness, and rapid heartbeat. The MCV (mean corpuscular volume) helps classify the type of anemia and guide further testing to determine the specific cause.
4. What does a high white blood cell count mean?
Elevated WBC (leukocytosis) most commonly indicates infection, inflammation, stress response, or tissue damage. Other causes include medications (especially corticosteroids), smoking, leukemia, or other blood disorders. The differential count helps identify which type of white cell is elevated, guiding diagnosis toward bacterial infection (neutrophilia), viral infection (lymphocytosis), allergic reaction (eosinophilia), or other specific causes.
5. What does low platelet count mean?
Low platelets (thrombocytopenia) increases bleeding risk. Causes include bone marrow disorders, immune destruction (ITP), medications, infections, pregnancy (gestational thrombocytopenia), liver disease with splenomegaly, or consumption in clotting disorders (DIC). Bleeding risk becomes clinically significant when platelets fall below 50 × 10⁹/L, with risk of spontaneous bleeding below 10-20 × 10⁹/L. Bleeding precautions and platelet transfusion may be necessary.
6. Does fasting affect CBC results?
No, fasting is not required for a CBC. Blood cell counts are not significantly affected by recent food intake. The test can be performed at any time of day. However, if other tests requiring fasting (such as lipid panel or glucose) are being drawn at the same time, the patient should follow fasting instructions for those tests.
7. What is the difference between relative and absolute counts in the differential?
Relative counts are percentages—what portion each cell type represents of total WBCs. Absolute counts are the actual number of each cell type per volume of blood, calculated by multiplying the percentage by the total WBC count. Absolute counts are more clinically useful. For example, 70% neutrophils might seem normal, but if total WBC is 2.0, the absolute neutrophil count is only 1.4 (neutropenia), even though the percentage is normal.
8. What is ANC and why is it important?
ANC (absolute neutrophil count) is calculated as (% neutrophils + % bands) × WBC ÷ 100. It’s the most important measure of infection-fighting ability. ANC <1.0 × 10⁹/L requires neutropenic precautions; ANC <0.5 × 10⁹/L is severe neutropenia with very high infection risk. Neutropenic fever (fever with ANC <0.5) is a medical emergency requiring immediate broad-spectrum antibiotics.
9. Can medications affect CBC results?
Yes, many medications affect CBC results. Chemotherapy suppresses all cell lines. Antibiotics can cause neutropenia or thrombocytopenia. Corticosteroids elevate WBC. Heparin can cause thrombocytopenia. Iron supplements increase hemoglobin over time. NSAIDs and anticoagulants don’t directly affect counts but increase bleeding risk with thrombocytopenia. Always review medication list when interpreting abnormal CBC results.
10. How often should CBC be monitored?
Frequency depends on clinical situation. Stable patients may need CBC annually or with symptoms. Patients on chemotherapy require CBC before each cycle and sometimes weekly. Patients on medications affecting blood counts (clozapine, carbimazole) need regular monitoring per protocol. Acute illness may require daily or more frequent monitoring. Always follow institutional protocols and provider orders for monitoring frequency.
📚 References
[1] Bain BJ. Blood Cells: A Practical Guide. 5th ed. Wiley-Blackwell; 2015.
[2] Clinical and Laboratory Standards Institute (CLSI). Procedures for the Collection of Diagnostic Blood Specimens by Venipuncture; Approved Standard—Seventh Edition. CLSI document GP41-A7. Wayne, PA; 2017.
[3] National Comprehensive Cancer Network (NCCN). Hematopoietic Growth Factors. NCCN Clinical Practice Guidelines in Oncology. 2023.
[4] Pagana KD, Pagana TJ, Pagana TN. Mosby’s Diagnostic and Laboratory Test Reference. 15th ed. Elsevier; 2021.
[5] Rodak BF, Fritsma GA, Keohane EM. Hematology: Clinical Principles and Applications. 5th ed. Elsevier; 2016.
[6] World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva: WHO; 2011.
[7] American Society of Clinical Oncology (ASCO). Neutropenia and Risk of Infection. https://www.cancer.net/navigating-cancer-care/side-effects/neutropenia
Disclaimer: This content is for informational and educational purposes only and is intended for nursing professionals and students. It does not constitute medical advice, diagnosis, or treatment. CBC interpretation requires clinical correlation and context. Normal ranges vary by laboratory, age, sex, and individual factors. While we strive for accuracy, clinical protocols vary; always refer to your specific facility’s guidelines, laboratory reference ranges, and current evidence-based practices before making clinical decisions.